QNT's Pre-IPO Perp Snaps to Reality as Quantinuum Opens at $68 on Nasdaq
QNT on Hyperliquid is a pre-IPO market tracking the implied share price of Quantinuum, the Honeywell-backed quantum computing company. On June 4 the real stock finally listed on Nasdaq, pricing at $60 and opening at $68. The perp had been implying roughly $101 a share, so its 32.93% drop is not a fundamentals crack — it is the market converging to where Quantinuum actually traded on day one.
Mover Brief
This Is a Resolution, Not a Sell-Off
The 32.93% drop in QNT is the most predictable kind of pre-IPO move: the contract found out what it was actually worth. xyz:QNT is a HIP-3 market on the implied price of Quantinuum Class A stock, and for weeks it traded as a guess. On June 4 the guessing ended — Quantinuum opened at $68 on the Nasdaq after pricing its IPO at $60 per share.
Back out the 32.93% decline and the perp had been implying roughly $101 a share before the print. That is the entire move: a market that had penciled in a triple-digit debut got anchored to a $60 strike and a $68 first trade. The down candle is the contract converging to a real, observable price — not new bad news about the company.
What Actually Priced
The listing itself was a strong one by deal-quality standards. Quantinuum priced 28 million Class A shares at $60, above its $53–$55 range, and raised $1.68 billion — the largest quantum computing IPO to date, led by J.P. Morgan and Morgan Stanley with a 4.2 million-share greenshoe. At the $68 open the company carried a market cap around $17.6 billion.
So the underwriters and the open both came in well below where the pre-IPO perp was sitting. For traders who were long the implied price near $100, the gap between speculative pre-IPO pricing and a real book of institutional demand at $60 is exactly the risk that resolves on debut day.
The Valuation Math Was Always the Bear Case
Even at $60, the number is steep. Quantinuum reported $30.9 million in 2025 revenue against a net loss of $192.6 million, with R&D running more than five times revenue. At a ~$14 billion implied cap on pricing, that is roughly 453x trailing sales — and Q1 2026 revenue actually fell to $5.2 million, lumpy the way enterprise quantum bookings tend to be.
None of that is new — it was in the prospectus the whole time. But it explains why the real book cleared at $60 rather than $100. The perp was pricing the narrative; the IPO priced the financials.
What to Watch From Here
With a real, continuously-traded reference now live on Nasdaq, the interesting question is basis: whether xyz:QNT tracks the listed stock tightly or drifts on its own thinner book. The post-debut tape — does $68 hold as support or fade back toward the $60 strike — now drives the perp far more than any pre-listing speculation did. Honeywell and Cambridge Quantum together retain roughly 82% of equity, so float is small and the eventual lockup expiry is the next structural overhang to mark on the calendar.
Sources & Provenance
Citations below are preserved as structured Postgres source rows for this brief.
Citations Preserved
6
Reference links carried forward from the published mover record.
Original Signal
Open source tweetMarket Route
Direct route preserved for readers who want to inspect the tracked Hyperliquid market behind this archive entry.
Already onboarded? Open tracked market- 1CNBC — Quantinuum opens at $68 in Nasdaq debutcnbc.com
- 2Quantinuum — pricing of upsized IPO at $60/sharefinance.yahoo.com
- 3IPOScoop — priced $5 above rangeiposcoop.com
- 4TechTimes — $14B valuation vs $31M revenuetechtimes.com
- 5AInvest — the $31M revenue valuation gapainvest.com
- 6The Quantum Insider — Quantinuum debuts after $1.68B raisethequantuminsider.com
This content is for informational purposes only and does not constitute financial advice. Trading perpetual futures involves substantial risk of loss.
Trade QNT on Hyperliquid
Use referral code HIPERWIRE for 4% off trading fees on your first $25M in volume.
Live Market Metrics
Monitor real-time open interest and funding for QNT.